Poor graft function, a significant and emerging clinical challenge post allogeneic stem cell transplantation

被引：0
|
作者：
Prabahran, Ashvind A. [1 ,2 ,3 ]
Ritchie, David S. [1 ,2 ,3 ]
机构：
[1] Royal Melbourne Hosp, Dept Clin Haematol, Peter MacCallum Canc Ctr, 300 Grattan St, Melbourne, Vic 3050, Australia
[2] Royal Melbourne Hosp, Australian Canc Res Fund Lab, Melbourne, Vic, Australia
[3] Univ Melbourne, Melbourne, Vic, Australia
来源：
LEUKEMIA & LYMPHOMA | 2020年 / 61卷 / 12期
关键词：
D O I：
10.1080/10428194.2020.1803301
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2786 / 2787
页数：2
相关论文
共 50 条
  • [1] Clinical features, pathophysiology, and therapy of poor graft function post-allogeneic stem cell transplantation
    Prabahran, Ashvind
    Koldej, Rachel
    Chee, Lynette
    Ritchie, David
    BLOOD ADVANCES, 2022, 6 (06) : 1947 - 1959
  • [2] Recurrent CMV Viremia Portends Poor Prognosis and Results in Significant Resource Utilization in Patients with Poor Graft Function Post Allogeneic Stem Cell Transplantation
    Prabahran, Ashvind Anand
    Chee, Lynette C. Y.
    Koldej, Rachel M.
    Yong, Michelle K.
    Ritchie, David
    BLOOD, 2021, 138
  • [3] Clinical Characteristics and Frequency of Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplantation
    Sahin, U.
    Yuksel, M. Kurt
    Merter, M.
    Gunduz, M.
    Ozdemir, Z. Narli
    Bozdag, S. Civriz
    Toprak, S. K.
    Topcuoglu, P.
    Arslan, O.
    Ozcan, M.
    Demirer, T.
    Ilhan, O.
    Akan, H.
    Beksac, M.
    Gurman, G.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S450 - S450
  • [4] Successful treatment of secondary poor graft function post allogeneic hematopoietic stem cell transplantation with eltrombopag
    Tang, Cen
    Chen, Feng
    Kong, Danqing
    Ma, Qinfen
    Dai, Haiping
    Yin, Jia
    Li, Zheng
    Chen, Jia
    Zhu, Xiaming
    Mao, Xinliang
    Wu, Depei
    Tang, Xiaowen
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [5] Successful treatment of secondary poor graft function post allogeneic hematopoietic stem cell transplantation with eltrombopag
    Cen Tang
    Feng Chen
    Danqing Kong
    Qinfen Ma
    Haiping Dai
    Jia Yin
    Zheng Li
    Jia Chen
    Xiaming Zhu
    Xinliang Mao
    Depei Wu
    Xiaowen Tang
    Journal of Hematology & Oncology, 11
  • [6] Immunologic Basis to Poor Graft Function Following Allogeneic Stem Cell Transplantation
    Prabahran, Ashvind Anand
    Koldej, Rachel M.
    Chee, Lynette C. Y.
    Ritchie, David
    BLOOD, 2022, 140 : 10453 - 10454
  • [7] CD34+Selected Cells "Boost" for Poor Graft Function Post Allogeneic Stem Cell Transplantation
    Mohty, Razan
    Ruggeri, Annalisa
    Battipaglia, Giorgia
    Malard, Florent
    Brissot, Eolia
    Belhocine, Ramdane
    Eder, Sandra
    Giannotti, Federica
    Dulery, Remy
    Mohty, Mohamad
    BLOOD, 2016, 128 (22)
  • [8] Eltrombopag Improves Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation
    Koshy, Nebu
    Master, Samip
    Leary, Cheri
    Bozeman, Amy
    Peyton-Thomas, Breanne
    Peddi, Prakash
    Devarakonda, Srinivas
    Mansour, Richard
    Mills, Glenn
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S284 - S286
  • [9] The economic cost of care in poor graft function following allogeneic stem cell transplantation
    Juneja, Manu
    Prabahran, Ashvind
    Rawicki, Mayani
    Chee, Lynette C. Y.
    Koldej, Rachel M.
    Ritchie, David S.
    BONE MARROW TRANSPLANTATION, 2025, 60 (01) : 97 - 99
  • [10] Evaluation of risk factors for and subsequent mortality from poor graft function (PGF) post allogeneic stem cell transplantation
    Prabahran, Ashvind
    Koldej, Rachel
    Chee, Lynette
    Wong, Eric
    Ritchie, David
    LEUKEMIA & LYMPHOMA, 2021, 62 (06) : 1482 - 1489
12345